Zinc: a potential star for regulating peritoneal fibrosis
Peritoneal dialysis (PD) is a commonly used renal replacement therapy for patients with end-stage renal disease (ESRD). During PD, the peritoneum (PM), a semi-permeable membrane, is exposed to nonbiocompatible PD solutions. Peritonitis can occur, leading to structural and functional PM disorders, re...
Saved in:
Main Authors: | Jian Li (Author), Xinyang Li (Author), Yangwei Wang (Author), Lingfei Meng (Author), Wenpeng Cui (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
by: Shunyun Xie, et al.
Published: (2022) -
Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
by: Fang Li, et al.
Published: (2022) -
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022) -
Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
by: Xiaohui Lu, et al.
Published: (2023) -
Delayed Administration of Nintedanib Ameliorates Fibrosis Progression in CG-Induced Peritoneal Fibrosis Mouse Model
by: Binbin Cui, et al.
Published: (2022)